Stage 4 lymphoma patients in India face critical decisions when selecting treatment centers that balance clinical innovation, cost accessibility, and personalized protocol design. Government hospitals, private chains, and coordination platforms each offer distinct approaches to advanced lymphoma care, requiring patients to evaluate facility capabilities against individual priorities. Key Takeaways Personalized stage 4 lymphoma care integrates molecular profiling, subspecializ